ERYPED 200 MG/5 ML SUSPENSION

Erythromycin Ethylsuccinate
$3.6046per ML

Strength

200 mg/5mL

NDC

24338013213

Classification

Brand

Dosage Form

SUSPENSION

Route

ORAL

Last Updated

4/17/2024

Active Ingredients

ERYTHROMYCIN ETHYLSUCCINATE

Approval Type

New Drug (NDA)

FDA Application

NDA050207

On Market Since

7/5/2011

Pharmacological Classes

Decreased Sebaceous Gland Activity
Macrolide Antimicrobial
Macrolide
Macrolides

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

0.0%

3Y

-0.1%

5Y

-0.1%

All

+166.6%